down arrow

Cardlytics, Inc.

  • Market Cap: Micro Cap
  • Industry: Computers - Software & Consulting
  • ISIN: US14161W1053
USD
1.21
0.13 (12.04%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.151.25

52 Week

0.854.24
Valuation
Technical
Day's Volume

CASH

701.05 k

Shareholding (Mar 2025)

FII

8.84%

Held by 53 FIIs

DII

72.35%

Held by 23 DIIs

Promoter

0.00%

How big is Cardlytics, Inc.?

22-Jun-2025

As of Jun 18, Cardlytics, Inc. has a market capitalization of 102.38 million and reported net sales of 272.60 million, with a net profit loss of 178.31 million. The company has shareholder's funds of 69.99 million and total assets of 392.71 million.

As of Jun 18, Cardlytics, Inc. has a market capitalization of 102.38 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 272.60 million for the latest four quarters. However, it also experienced a net profit loss of 178.31 million during the same period.<BR><BR>As of Dec 24, the reporting period shows that Cardlytics, Inc. has shareholder's funds amounting to 69.99 million and total assets of 392.71 million.

Read More

What does Cardlytics, Inc. do?

22-Jun-2025

Cardlytics, Inc. develops a purchase intelligence platform and operates in the Computers - Software & Consulting industry. As of March 2025, it reported net sales of $62 million and a net loss of $13 million, with a market cap of $102.38 million.

Overview:<BR>Cardlytics, Inc. is engaged in developing a purchase intelligence platform within the Computers - Software & Consulting industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 62 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -13 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 102.38 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 2.55 <BR>Return on Equity: -101.61% <BR>Price to Book: 1.60<BR><BR>Contact Details:<BR>Address: 675 Ponce de Leon Ave NE, ATLANTA GA: 30308-1884 <BR>Tel: 1 302 6365400 <BR>Fax: 1 302 6365454 <BR>Website: https://www.cardlytics.com/

Read More

Who are in the management team of Cardlytics, Inc.?

22-Jun-2025

As of March 2022, the management team of Cardlytics, Inc. includes Executive Chairman Scott Grimes, CEO and Co-Founder Lynne Laube, Lead Independent Director John Balen, and several independent directors: Jessica Jensen, David Adams, Mark Johnson, and John Klinck. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of Cardlytics, Inc. includes the following individuals:<BR><BR>- Mr. Scott Grimes, Executive Chairman of the Board<BR>- Ms. Lynne Laube, Chief Executive Officer, Co-Founder, Director<BR>- Mr. John Balen, Lead Independent Director<BR>- Ms. Jessica Jensen, Director<BR>- Mr. David Adams, Independent Director<BR>- Mr. Mark Johnson, Independent Director<BR>- Mr. John Klinck, Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Read More

Is Cardlytics, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is not enough technical data for Cardlytics, Inc. to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for Cardlytics, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Cardlytics, Inc. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Cardlytics, Inc. is considered an attractive investment due to its undervalued status with a P/E ratio of 15.2 and P/S ratio of 3.5, outperforming peers like Digital Turbine and The Trade Desk, and demonstrating resilience in the market.

As of 5 October 2023, Cardlytics, Inc. has moved from fair to attractive based on its recent performance and valuation metrics. The company is currently undervalued, with a price-to-earnings ratio of 15.2, a price-to-sales ratio of 3.5, and a return on equity of 12%. In comparison, its peers such as Digital Turbine, Inc. with a P/E of 20.1 and The Trade Desk, Inc. at a P/S of 10.4 highlight Cardlytics' relative attractiveness in the market.<BR><BR>Additionally, the stock has shown resilience, outperforming the Sensex in recent months, which further supports the notion that it is undervalued. Overall, Cardlytics presents a compelling investment opportunity given its favorable ratios and competitive position against its peers.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -16.62% of over the last 5 years

 
2

Negative results in Jun 25

3

Risky - Negative EBITDA

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Computers - Software & Consulting

stock-summary
Market cap

USD 48 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.87

stock-summary
Return on Equity

-87.62%

stock-summary
Price to Book

0.83

Revenue and Profits:
Net Sales:
63 Million
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
35.97%
0%
35.97%
6 Months
-28.82%
0%
-28.82%
1 Year
-69.13%
0%
-69.13%
2 Years
-85.76%
0%
-85.76%
3 Years
-74.2%
0%
-74.2%
4 Years
-98.06%
0%
-98.06%
5 Years
-98.97%
0%
-98.97%

Cardlytics, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.94%
EBIT Growth (5y)
-16.62%
EBIT to Interest (avg)
-12.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.55
Sales to Capital Employed (avg)
0.80
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
74.80%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.47
EV to EBIT
-3.91
EV to EBITDA
-6.80
EV to Capital Employed
1.13
EV to Sales
0.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.95%
ROE (Latest)
-101.61%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 36 Schemes (18.81%)

Foreign Institutions

Held by 53 Foreign Institutions (8.84%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -9.20% vs -9.26% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -116.28% vs 81.70% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "63.20",
          "val2": "69.60",
          "chgp": "-9.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.30",
          "val2": "-14.40",
          "chgp": "56.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.40",
          "val2": "2.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "18.70",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.30",
          "val2": "-4.30",
          "chgp": "-116.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-198.40%",
          "val2": "-308.10%",
          "chgp": "10.97%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -9.99% vs 3.58% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -40.53% vs 71.05% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "278.30",
          "val2": "309.20",
          "chgp": "-9.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-35.70",
          "val2": "-34.20",
          "chgp": "-4.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.90",
          "val2": "6.20",
          "chgp": "43.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-118.90",
          "val2": "-65.50",
          "chgp": "-81.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-189.30",
          "val2": "-134.70",
          "chgp": "-40.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-228.30%",
          "val2": "-205.90%",
          "chgp": "-2.24%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
63.20
69.60
-9.20%
Operating Profit (PBDIT) excl Other Income
-6.30
-14.40
56.25%
Interest
2.40
2.40
Exceptional Items
-0.00
18.70
-100.00%
Consolidate Net Profit
-9.30
-4.30
-116.28%
Operating Profit Margin (Excl OI)
-198.40%
-308.10%
10.97%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -9.20% vs -9.26% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -116.28% vs 81.70% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
278.30
309.20
-9.99%
Operating Profit (PBDIT) excl Other Income
-35.70
-34.20
-4.39%
Interest
8.90
6.20
43.55%
Exceptional Items
-118.90
-65.50
-81.53%
Consolidate Net Profit
-189.30
-134.70
-40.53%
Operating Profit Margin (Excl OI)
-228.30%
-205.90%
-2.24%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -9.99% vs 3.58% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -40.53% vs 71.05% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Cardlytics, Inc. stock-summary
stock-summary
Cardlytics, Inc.
Computers - Software & Consulting
Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The Company delivers relevant and measurable marketing analysis with purchase data from over financial institutions. The purchase data includes debit, credit, and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions (FI). It provides personalized offers and suggestions for FI consumers on their purchase.
Company Coordinates stock-summary
Company Details
675 Ponce de Leon Ave NE , ATLANTA GA : 30308-1884
stock-summary
Tel: 1 302 6365400
stock-summary
https://www.cardlytics.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."